Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A new Future Vaccines Manufacturing Hub aims to make the UK the global centre for discovering and manufacturing next-generation vaccines.

Close up of a single vaccine dose being prepared from a vial

The Engineering and Physical Sciences Research Council (EPSRC), part of UK Research and Innovation (UKRI), has announced a £12 million investment to fund the Future Vaccines Manufacturing Hub for the next seven years, up to 2030.

Led by the University of Oxford and University College London (UCL), the Hub aims to make the UK the global centre for vaccine discovery, development, and manufacture. This will help save lives by enabling rapid roll-out of highly effective new vaccines for frontline use.

Minister of State for Science, Research & Innovation George Freeman said: ‘As part of our record £52 billion investment in public research and development over the next 3 years, we are investing in novel vaccine development, pandemic preparedness, and agri-food security as some of the biggest global challenges we face.’

‘The UK has a long history of pioneering vaccine research and development and this funding will help ensure the UK is well placed to help develop the science, technology and innovation the UK and the planet needs to ensure economic resilience in the face of growing global threats.’

The Future Vaccines Manufacturing Hub will be co-directed by Professor Dame Sarah Gilbert at the University of Oxford and Prof Martina Micheletti at UCL.

The Hub is a follow-on from Vax-Hub1, formed in 2018, which helped the Oxford University-AstraZeneca collaboration produce one of the world’s first COVID-19 vaccines and deliver 2.9 billion doses to 180 countries worldwide.

Read the full story on the University of Oxford website